Individuals with chronic obstructive pulmonary disease (COPD) experience improved breathing symptoms and dyspnea with use of automated oxygen administration. Automated oxygen administration (AOA) was ...

Please provide your email address to receive an email when new articles are posted on . This analysis focused on adults with moderate to severe COPD without an exacerbation during the ENHANCE trials.

In addition to pharmacologic interventions and oxygen, there are a number of nonpharmacologic strategies that can be beneficial in the management of dyspnea. By changing a patient's physical ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

A yearly influenza vaccine reduces serious illness and death in COPD patients by nearly 50%. Pneumococcal polysaccharide vaccine is also recommended for COPD patients aged 65 years and older or those ...

Please provide your email address to receive an email when new articles are posted on . Patients who received an initial diagnosis with point-of-care ultrasonography (POCUS) vs. the standard of care ...

Editor's note: Find the latest long COVID news and guidance in Medscape's Long COVID Resource Center. Poor-quality sleep and irregular sleep could be important drivers of breathlessness in patients ...

What Is Dyspnoea And What Are Its Causes? Before we delve deep into dyspnoea, let us explain what it actually is. “Dyspnoea is a feeling of difficult or uncomfortable breathing, often described as ...